Advances in Cytoprotective Drug Discovery
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 35255
Special Issue Editors
Interests: bioactive compounds; secondary metabolites; marine invertebrates; marine fungi; cytoprotection; cytotoxicity; structure–activity relationships
Special Issues, Collections and Topics in MDPI journals
Interests: biochemistry; cell biology; structure and function of biological membranes; mechanism of biological activity of natural and synthetic biologically active substances; new drug discovery; molecular targets; toxicology; ecotoxicology; biomarkers; biosensors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is well known that cytoprotection is a process by which chemical compounds provide protection to cells against noxious impacts. The mechanisms for protecting cells from various adverse factors, including physical ones, have attracted the steady attention of researchers. The cells have their own evolutionary features in the pathways for decreasing influence of toxins and other stress factors, which has resulted in saving cell viability and functionality. The autophagy, activated C protein (ACP), heat shock proteins (HSPs), glutathione S-transferases (GSTs), and different signaling pathways (such as Keap1-Nrf2-ARE, UCP2-SIRT3, JAK/STAT and others) were reported as cellular cytoprotective mechanisms realised during various disorders. Additionally, natural and synthetic compounds capable of inducing or modulating these protective molecular targets are important for cytoprotective drug discovery. Annualy, more that 200 papers about new as well as known substances are published on their protective activity against oxydative changes, protein aggregation, apoptosis, mitochondrial and endoplasmic reticulum dysfunction, etc. Some of these substances, for example, resveratrol, astaxanthin, melatonin, carbenoxolone, atorvastatin, echinochrome, and others, are now used as officially approved cytoprotective drugs.
With this Special Issue, we wish to offer a platform for papers describing isolation and identification of natural products’ various demonstrated types of cytoprotective effects, as well as studying of cytoprotective synthetic compounds. Moreover, manuscripts describing the molecular mechanism of cytoprotective action of promising drug candidates are also welcome.
Dr. Ekaterina Yurchenko
Dr. Dmitry Aminin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Natural products
- Synthetic compounds
- Cell protection
- Neuroprotection
- Cardiovascular protection
- Hepatoprotection
- Gastric protection
- Renal protection
- Skin protection
- Oxidative stress protection
- New drug discovery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.